5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
NEUTRAL | NEUTRAL | NEUTRAL | BUY | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 0.84▲ | 0.84▲ | 0.84▲ | 0.86▲ | 0.86▲ |
MA10 | 0.87▲ | 0.87▲ | 0.87▲ | 0.85▲ | 0.89▼ |
MA20 | 0.89▼ | 0.89▼ | 0.89▼ | 0.87▲ | 0.94▼ |
MA50 | 0.87▲ | 0.88▲ | 0.88▲ | 0.90▼ | 1.01▼ |
MA100 | 0.89▼ | 0.90▼ | 0.92▼ | 0.94▼ | N/A |
MA200 | 0.95▼ | 0.96▼ | 0.94▼ | 1.01▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.004▼ | -0.004▼ | -0.004▼ | 0.004▲ | -0.007▼ |
RSI | 50.761▲ | 50.730▲ | 50.564▲ | 51.633▲ | 45.859▼ |
STOCH | 31.093 | 31.093 | 31.093 | 56.234 | 25.528 |
WILL %R | -35.787 | -39.322 | -39.322 | -39.759 | -74.000 |
CCI | 14.142 | 3.861 | -0.333 | 88.673 | -59.552 |
Thursday, August 14, 2025 04:19 AM
So should Estrella Immunopharma (NASDAQ:ESLA) shareholders be worried about its cash burn? In this report, we will consider the company's annual negative free cash flow, henceforth referring to it as ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/08/25 | 0.884 | 0.884 | 0.884 | 0.884 | 11,050 |
14/08/25 | 0.8413 | 0.865 | 0.8413 | 0.8604 | 2,217 |
13/08/25 | 0.92 | 0.92 | 0.8497 | 0.8497 | 3,461 |
12/08/25 | 0.85 | 0.88 | 0.8469 | 0.865 | 4,277 |
11/08/25 | 0.823 | 0.88 | 0.823 | 0.865 | 8,131 |
08/08/25 | 0.83 | 0.87 | 0.823 | 0.823 | 14,000 |
07/08/25 | 0.817 | 0.866 | 0.817 | 0.842 | 31,500 |
06/08/25 | 0.8495 | 0.8499 | 0.8394 | 0.8394 | 277 |
05/08/25 | 0.82 | 0.87 | 0.82 | 0.85 | 9,100 |
04/08/25 | 0.87 | 0.87 | 0.784 | 0.828 | 21,000 |
|
|
||||
|
|
||||
|
|